Stay updated with breaking news from John Grimaldi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As of midnight Saturday, Gov. Charlie Baker’s mask mandate is no more and all remaining COVID-19 restrictions in Massachusetts have been lifted.In place of...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Yumanity Therapeutics Announces Study Demonstrating In Vivo Efficacy of YTX-7739 in a ... Yumanity Therapeutics IncApril 6, 2021 GMT YTX-7739 demonstrates efficacy, including increased median overall survival, both as a single agent and in combination with temozolomide, the standard-of-care for GBM Shared therapeutic target with Parkinson’s disease expands potential utility of YTX-7739 to non-neurodegenerative diseases SNO/NCI Joint Symposium: Targeting CNS Tumor Metabolism BOSTON, April 06, 20...
John Grimaldi “We’re not giving up on our efforts to eliminate the unfair income tax on Social Security benefits. The Senior Citizens Tax Elimination Act is being reintroduced and the Association of Mature American Citizens [AMAC] will be doing what it takes to encourage lawmakers to support the measure,” says Bob Carlstrom, president of AMAC Action, the association’s senior advocacy affiliate. The original Social Security and tier 1 railroad retirement benefits were specifically exempted from income taxes when they were created in the mid-1930s. “After all, workers pay for them w...
Share: Shares of Yumanity to commence trading on Nasdaq under new ticker symbol "YMTX" on December 23, 2020 $33.6 million common stock private investment in public equity ("PIPE") transaction closes concurrently with the merger BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ:YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that its reverse merger with Proteostasis Therapeutics, Inc. closed on December 22, 2020, following the approval of...